In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Tox21_301079 Drug Master File in Korea (Tox21_301079 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Tox21_301079. The MFDS reviews the Tox21_301079 KDMF as part of the drug registration process and uses the information provided in the Tox21_301079 KDMF to evaluate the safety and efficacy of the drug.
After submitting a Tox21_301079 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Tox21_301079 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Tox21_301079 suppliers with KDMF on PharmaCompass.